About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, June 29th, 2015

The QualityStocks
Daily Stock List


Mass Megawatts Wind Power, Inc. (MMMW)

Actual Gains, PennyStockRumors.net, and PricelessPennyStocks reported earlier on Mass Megawatts Wind Power, Inc. (MMMW), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Mass Megawatts Wind Power, Inc. is a leader in the development of low-cost, clean energy systems. The design of these is to meet the increasing global demand for energy through the use of environmentally-friendly technologies. This includes patented innovations for solar power systems that provide an economical option for commercial and residential users interested in green energy applications. The Company’s plan is to build more than 1000 megawatts over the next six years. As the units are constructed, they will be immediately placed into service. Mass Megawatts Wind Power lists is headquartered in Worcester, Massachusetts.

The Company offers an assortment of low-cost, high-efficiency, solar power solutions. These are suited for business and residential locations. The design of each system is for durable, long-term, maintenance-free operation, with scalable capacity to meet the energy needs of residential, small commercial, and also large commercial customers. Mass Megawatts offers affordable, renewable-energy plans to residential and commercial electricity users in several states. These include New York, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Delaware, and Illinois.   

The Company has developed a new solar tracking technology. This technology substantially increases the level of energy produced by solar power systems. The patent pending Mass Megawatts 'Solar Tracking System' (STS) is a complete solar power system. The design of it is to continually adjust the position of solar panels to receive the optimal level of direct sunlight throughout the day. The Mass Megawatts STS uses a low-cost structure that adds stability to the overall system while improving solar energy production by 22 to 28 percent.

Mass Megawatts Wind Power announced in May 2014 that Worcester, Massachusetts would be the site of its initial Community Solar project. This project will allow residents and businesses to directly invest in solar power. With this plan, Mass Megawatts would develop and maintain solar power systems that investors can secure ownership in with the purchase of shares in 1 kW increments. The value of all solar power generation, including tax incentives, would be credited to the investors in proportion to their investment.

The Company introduced the Frankenstein Solar Power Monster, a new solar power tracking system on October 27, 2014. Mass Megawatts has considerably reduced the cost of solar energy with its patent-pending, Solar Power Tracking System (STS) through the use of an advanced design with fewer electrical components and moving parts.

Today, Mass Megawatts Wind Power announced that it has completed development of its advanced, Solar-Power Tracking System (STS), scheduled for customer delivery. The design of the first completed unit, of a multi-unit sale, has been upgraded to protect against extreme weather, including winds up to 90 mph, and to streamline manufacturing processes. The advanced structural design will minimize the requirement for repairs and maintenance. It comes with a full performance guarantee over the first 10 years of operation. Mass Megawatts is working to fill current sales orders while expanding infrastructure to meet demand in the second half of 2015 and into 2016.

Mass Megawatts Wind Power, Inc. (MMMW), closed Monday's trading session at $0.014, up 68.67%, on 3,198,015 volume with 154 trades. The average volume for the last 60 days is 216,476 and the stock's 52-week low/high is $0.0065/$0.045.

Soligenix, Inc. (SNGX)

PennyStocks24, Pennybuster, Streetwise Reports, and InvestorPlace reported on Soligenix, Inc. (SNGX), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Princeton, New Jersey-headquartered Soligenix, Inc. is a late-stage biopharmaceutical company. It is developing products that address unmet medical needs in the areas of inflammation, oncology, and biodefense. The Company’s proprietary vaccine thermostabilization technology is ThermoVax™.  Soligenix’s areas of emphasis include a therapeutics segment devoted to the development of products for orphan diseases and areas of unmet medical need. This includes cutaneous T-cell lymphoma, oral mucositis, pediatric Crohn's disease, acute radiation enteritis, as well as Graft-versus-Host disease (GVHD).

Soligenix’s second area of emphasis is a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, anthrax exposure, gastrointestinal acute radiation syndrome, and melioidosis. The Company is developing proprietary formulations of oral BDP (beclomethasone 17,21-dipropionate) for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation. This includes pediatric Crohn's disease (SGX203) and acute radiation enteritis (SGX201).

Soligenix is also advancing its novel innate defense regulator (IDR) technology SGX942 for the treatment of oral mucositis and SGX301, its novel first-in-class photodynamic technology utilizing synthetic hypericin with safe visible light, for the treatment of cutaneous T-cell lymphoma.

The Company’s biodefense products in development include a recombinant subunit vaccine called RiVax™. The design of it is to protect against the lethal effects of exposure to ricin toxin. Additionally, it is developing VeloThrax™, a vaccine against anthrax exposure. It is also developing OrbeShield™ for the treatment of gastrointestinal acute radiation syndrome (GI ARS) under a BARDA (Biomedical Advanced Research and Development Authority) contract award.

Furthermore, Soligenix has an exclusive global collaboration with Intrexon Corp. (XON). The focus of it is on the joint development of a treatment for Melioidosis, a high priority biothreat and an area of unmet medical need.

Soligenix has initiated a development agreement with Emergent BioSolutions to implement a commercially viable, scalable production technology for the RiVax™ drug substance protein antigen.  Soligenix will transfer the manufacturing processes and analytics to Emergent BioSolutions to conduct process development work that could potentially lead to a future commercial manufacturing collaboration. RiVax™ has been granted orphan drug designation by the Food and Drug Administration (FDA) for the prevention of ricin intoxication.

Last week, Soligenix announced that it will be working with the National Organization for Rare Disorders (NORD) and the Cutaneous Lymphoma Foundation (CLF) to educate and recruit patients for its pivotal Phase 3 clinical study of SGX301 (synthetic hypericin) in the treatment of cutaneous T-cell lymphoma (CTCL). SGX301 has previously been granted orphan drug and fast track designations from the US Food and Drug Administration (FDA) for the first-line treatment of CTCL, a rare disease and a class of non-Hodgkin's lymphoma, a kind of cancer of the white blood cells that are an essential element of the immune system. 

Soligenix, Inc. (SNGX), closed Monday's trading session at $2.30, down 6.12%, on 418,429 volume with 427 trades. The average volume for the last 60 days is 150,555 and the stock's 52-week low/high is $0.91/$2.95.

Arch Therapeutics, Inc. (ARTH)

Wall Street Resources, RedChip, and PennyStocks24 reported on Arch Therapeutics, Inc. (ARTH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTC Bulletin Board-listed Arch Therapeutics, Inc. is a medical device company that is developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. The Company’s aim is to develop and commercialize products based on its ground-breaking technology platform. This platform makes surgery and interventional care faster and safer for patients. Arch Therapeutics has its corporate head office in Wellesley, Massachusetts.

The underlying technology, exclusively licensed from a leading university, supports a pioneering platform of smart materials, which fulfill the criteria as a solution for a specialized field the Company calls, “stasis and barrier applications.” Arch Therapeutics’ flagship development stage product candidate is called AC5™ (AC5 Surgical Hemostatic Device™). This is a synthetic peptide consisting of naturally occurring amino acids.

AC5™ is undergoing design to smoothly achieve hemostasis in minimally invasive (laparoscopic) and open surgical procedures. Its solution smartly controls the movement of fluids and substances. AC5™ stops bleeding fast. AC5™ conforms to irregular wound geometry and assists in maintaining a clear field of vision directly into the wound area.

AC5™, when squirted or sprayed onto a wound, rapidly intercalates into the nooks and crannies of the connective tissue where it builds itself into a physical, mechanical structure. That structure provides a barrier to leaking substances (including blood and other bodily fluids) regardless of kind of surgery or, based on early data, clotting ability, and healing occurs normally.

Arch Therapeutics indicates that in preclinical tests, AC5™ has been simple, effective, and versatile. To date, biocompatibility has been excellent and healing of tissue treated with the device has been normal.

At the beginning of June, Arch Therapeutics announced that it executed a collaboration agreement with CÚRAM Centre for Research in Medical Devices (CÚRAM). CÚRAM is a new center of excellence for research based in Galway, Ireland. It aims to radically improve health outcomes for patients through developing and collaborating on the development of "smart" medical devices.

Moreover, this month, Arch Therapeutics announced that it obtained data from a preclinical toxicity test for AC5™ that show the device was well-tolerated and classified as "not toxic" in a standardized test of systemic toxicity. The systemic toxicity animal test is a major component of the biocompatibility test panel that a medical device must typically complete successfully before use in human beings.

Arch Therapeutics, Inc. (ARTH), closed Monday's trading session at $0.228, up 0.88%, on 496,240 volume with 118 trades. The average volume for the last 60 days is 258,074 and the stock's 52-week low/high is $0.15/$0.27.

Lexaria Corp. (LXRP)

PennyPickAlerts, PennyStocks24, MassiveStockProfits, Penny Stock Circle, 1-2-3 Stock Alerts, Jet-Life Penny Stocks, Equity Observer, and Shiznit Stocks reported on Lexaria Corp. (LXRP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Lexaria Corp. is a food sciences company focused on the delivery of cannabinoid compounds obtained from legal, agricultural hemp, through gourmet foods based upon its proprietary infusion technologies. Most of what the Company does currently is research and formulate food products that contain cannabidiol using an inventive, proprietary technology upon which it has two patents pending. OTCQB-listed Lexaria is headquartered in British Columbia.

Cannabinoids are a class of compounds found in a number of species of plants, like some Echinacea species, and more abundantly, in agricultural (or industrial) hemp where cannabidiol (CBD) can consist of 35 percent or more of the plant’s extracts.

The Company is active in two market segments, all focused on one’s comfort and well-being. It produces and sells edible consumer products infused with cannabidiol and available for sale in all 50 States. It also owns two patents pending for the infusion of CDBs within lipids. The Company is presently investigating methods of expanding its intellectual property (IP) in this new field of research.

Lexaria has two distinctive consumer product brands. These are ViPova™ and Lexaria Energy. Both brands use patent pending technology to infuse cannabidiol within lipids in popular foods. The Company has a patent-pending method through which it infuses its organically sourced high purity CBD-oil inside the molecules of other ingredients.

Lexaria introduced ViPova™ black tea infused with CBD in January of this year. This is a Chinese black tea from the province of Yunnan. It is CBD-infused within dried evaporated non-fat milk.

Lexaria Energy products use the Company’s patent pending technology to efficiently deliver CBD in nutritious and appetizing formulations. Through its Lexaria Energy brand, Lexaria is about to launch the Lexaria Energy Bar. This is a CBD-infused protein bar.

Lexaria has made major gains in developing and implementing certain technologies related to the patent pending methods designed to improve bioavailability of certain molecules. This includes CBD and THC. The Company has now included in its patent pendings, applications for lipophilic delivery of Nicotine, NSAIDs, and certain vitamins.

Lexaria Corp. (LXRP), closed Monday's trading session at $0.175, up 9.38%, on 311,641 volume with 39 trades. The average volume for the last 60 days is 196,681 and the stock's 52-week low/high is $0.04/$0.33.

Abtech Holdings, Inc. (ABHD)

Greenbackers reported recently on Abtech Holdings, Inc. (ABHD), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Scottsdale, Arizona-based Abtech Holdings, Inc. is a full-service environmental technologies and engineering firm. AbTech Industries, Inc. is a subsidiary of AbTech Holdings. It provides creative solutions to communities, industry, and governments addressing issues of water pollution and contamination. The Company offers solutions for Stormwater Management, Oil & Gas Water Treatment, and Industrial Water Treatment. Abtech Holdings lists on the OTC Markets Group’s OTCQB.
Abtech Holdings integrates its native advanced technologies along with third-party technologies and systems to provide effective and economical solutions to its customers. Abtech commenced marketing of produced water and industrial wastewater treatment, and formed its engineering subsidiary AEWS Engineering in 2012.

AEWS is an independent civil and environmental engineering firm partnered with foremost research and engineering universities. The foundation of Abtech’s products are on polymer technologies, which can remove hydrocarbons, sediment, and other foreign elements in stormwater runoff, flowing water, and industrial process and wastewater.

Abtech Holdings’ offerings include the antimicrobial technology- Smart Sponge® Plus. This technology is effective in reducing coliform bacteria found in stormwater, industrial wastewater, and municipal wastewater. Smart Sponge® Plus is registered with the Environmental Protection Agency (EPA).

Abtech has deployed and validated onsite its first mobile water pre-treatment system, focused on oil recovery and hydrocarbon removal for the treatment of flowback and produced water for the on-shore Oil & Gas industry. This pre-treatment system integrates its Smart Sponge® technology. The design of it is to operate in advance of other treatment systems, increasing overall efficiency and lowering treatment cost.

In May, Abtech Holdings reported net revenues for the three months ended March 31, 2015 of approximately $204,000 versus $75,000 for the same period of the prior year and $235,000 in Q4 of 2014.  The increase in revenue was chiefly because of the fulfillment of the initial order of roughly $107,000 from Naylor Industries, the Company's new distributor in the UK for product sales.  In addition, Abtech recognized approximately $14,500 of revenue from a stormwater contract with Nassau County, which has since been suspended as of May 12, 2015.

Abtech Holdings, Inc. (ABHD), closed Monday's trading session at $0.054, down 10.00%, on 58,705 volume with 5 trades. The average volume for the last 60 days is 114,659 and the stock's 52-week low/high is $0.05/$0.45.


The QualityStocks
Company Corner


One World Holdings, Inc. (OWOO)

The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0074, up 5.71%, on 21,918,865 volume with 230 trades. The stock’s average daily volume over the past 60 days is 7,829,541, and its 52-week low/high is $0.0008/$0.0425.

One World Holdings, Inc. reported an initial order from Hallmark Stores for the Prettie Girls!(TM) Tween Scene multicultural fashion and play dolls. This order resulted from a preliminary outreach to the company by the Hallmark buying team. The placement of these dolls within Hallmark Stores across the country will bring additional exposure to the Prettie Girls! brand.

One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.

In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.

The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.

Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer

One World Holdings, Inc. Company Blog

One World Holdings, Inc. News:

One World Holdings, Inc. (OWOO) Announces Initial Order from Hallmark Stores

Based on Prettie Girls! Dolls Retail Success; Tonner Doll Company to Acquire Equity Stake in One World Holdings, Inc.

The One World Doll Project to Give Updates on National Wal-Mart Roll Out and Business Expansion Plans on Quarterly Conference

The Aristocrat Group Corp. (ASCC)

The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $1.40, up 12.72%, on 3,370 volume with 8 trades. The stock’s average daily volume over the past 60 days is 1,275, and its 52-week low/high is $1.00/$7.50.

The Aristocrat Group Corp. (ASCC) is a brand management company specializing in the discovery and promotion of unique brands with mass market appeal. The company strategizes to capitalize on unprecedented brand-building opportunities, and is working to build a portfolio of successful brands to compete alongside industry leaders like Moet Hennessy, Louis Vuitton, Diageo PLC, and Brown-Forman Corp.

Luxuria Brands, an ASCC subsidiary, is tasked with brand management and sustainability, specifically in the beverage alcohol sector, where the company will develop and market brands using strategic, cross-cultural branding initiatives that engage businesses and consumers. Vodka boasts a significantly high market share, accounting for 25 percent of all distilled spirits sold in the United States. What this means for ASCC investors is that they have a remarkable chance to capitalize on a proven commodity and business model for distribution.

To this accord, ASCC's current portfolio of premium luxury goods brands includes top-shelf distilled spirits like RWB Vodka, an ultra-premium handcrafted spirit that has already met remarkable success, including multiple awards. The market for vodka is estimated to be at almost 60 million cases per year in the United States alone, and beverages priced at a premium level are garnering top-dollar returns for businesses and investors. Strategizing to capitalize on this powerful sector, ASCC plans to debut a second lifestyle vodka brand later this year.

ASCC's experienced and visionary management team is committed to creating a solid foundation for innovative technologies and models, ranging from mobile couponing to social engagement, that drive business forward. Building on its established presence in the lucrative beverage alcohol sector, ASCC is emerging as a trusted platform where fledgling ideas turn into commercial successes. Disclaimer

The Aristocrat Group Corp. Company Blog

The Aristocrat Group Corp. News:

ASCC Details Big Box Vodka’s Revolutionary Packaging

ASCC Creates New Market Segment with Innovative Bag-in-Box Vodka

ASCC to Enter New Market as a Standout

Cleartronic, Inc. (CLRI)

The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.055, up 27.91%, on 222,050 volume with 14 trades. The stock’s average daily volume over the past 60 days is 65,300, and its 52-week low/high is $0.04/$0.5499.

Cleartronic, Inc. (CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.

VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.

A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.

Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer

Cleartronic, Inc. Company Blog

Cleartronic, Inc. News:

Cleartronic, Inc. (CLRI) Begins Nationwide Retail Store Project

Cleartronic, Inc. (CLRI) Subsidiary Signs Agreement with Houston-Galveston Area Council

Cleartronic, Inc. (CLRI) on the "Your Monies Worth" Show

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.005, even for the day. The stock’s average daily volume over the past 60 days is 114,021, and its 52-week low/high is $0.0013/$0.008.

Consorteum Holdings, Inc. (CSRH) has spent the last 3 years developing relationships and licensing agreements to take the center stage in the emerging market of mobile gaming. The company has the capability to deliver rich mobile content to end users who will use their smart phones in ways that could not even have been imagined five years ago.

Specializing in delivery of mobile content, mobile payment solutions and products through a mix of on-deck partnerships, license agreements, and joint venture revenue share arrangements, the company operates as a technology and services aggregator to meet the diverse needs of its client base. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

ThreeFiftyNine Inc., a wholly owned subsidiary, hired a software development team that had previously designed the world’s first regulatory compliant mobile platform for delivery of gaming content created by a third party. The platform, which has met the rigorous standards of the Nevada Gaming Board, the gold standard in regulatory gaming, represents the first generation software delivery platform for mobile devices. The development team spent the past 5 years and millions of dollars in non-recurring engineering costs to complete the development of the platform. At the heart is the capability to deliver any digital content across any cellular network to any mobile device. This key differentiator makes it possible for Consorteum to approach many different markets that are in the business of providing mobile connectivity and mobile content.

Consorteum’s mobile initiatives will benefit multiple business verticals. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings Signs License Agreement With NYG Holdings

Consorteum Holdings Signs Mobile Application Development Contract With Bet Butler Limited

Consorteum Holdings Launches New Mobile Results App for Popular Keno Game

Loans4Less.com, Inc. (LFLS)

The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.18, even for the day. The stock’s average daily volume over the past 60 days is 2,788, and its 52-week low/high is $0.0248/$0.20.

Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.

Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.

The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.

Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulted on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer

Loans4Less.com, Inc. Company Blog

Loans4Less.com, Inc. News:

LOANS4LESS.COM Enters into an Acquisition Agreement with 321LEND

Loans4Less.com, Inc. Enters into an Investment Banking Agreement with WestPark Capital, Inc. and Seeks Bank Strategic Partner for National Mortgage Broker Origination and Brand Exposure Opportunity

Loans4Less.com Seeks a Merger, Joint Venture Partner and/or Investor for National Loan Origination and Brand Exposure Opportunity


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



1-2-3 Stock Alerts





By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251